STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), represents the most aggressive and mortal subtype of breast cancer. Currently, only a few treatment options are avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jiang-Jiang, Yan, Li, Zhang, Jia, Zhang, Wei-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518732/
https://www.ncbi.nlm.nih.gov/pubmed/31088482
http://dx.doi.org/10.1186/s13046-019-1206-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518732/
https://www.ncbi.nlm.nih.gov/pubmed/31088482
http://dx.doi.org/10.1186/s13046-019-1206-z

Ejemplares similares